ArticlePharmaceutics2025

Lymph-Targeted Delivery of CUR-NLCs Enhances Oral Bioavailability: Evidence from a Double-Catheterized Rat Model.

Haoming Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.